Research Square (Research Square),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Oct. 31, 2023
Abstract
Alzheimer's
disease
(AD)
is
a
neurodegenerative
characterized
by
amyloid-beta
(Aβ)
aggregation,
neuroinflammation,
oxidative
stress,
and
dysfunction
in
the
mitochondria
cholinergic
system.
In
this
study,
synthesis
of
chitosan-polylactic
acid-loaded
magnesium
oxide
nanocomposite
(CH/PLA/MgONCs)
was
examined
using
green
precipitation
method.
The
synthesized
CH/PLA/MgONCs
were
confirmed
UV-Vis
spectrum,
FT-IR,
SEM-EDAX,
physical
properties.
experiments
carried
out
male
Wistar
rats
injecting
streptozotocin
(STZ)
bilaterally
into
brain's
ventricles
through
intracerebroventricular
(ICV)
route
at
dose
3
mg/kg.
We
also
evaluated
effects
doses
10
To
assess
cognitive
induced
ICV-STZ,
we
performed
behavioral,
biochemical,
histopathological
analyses.
our
study
results,
spectrum
analysis
showed
285
nm,
FT-IR
analyses
that
various
functional
groups
present,
SEM-EDAX
cauliflower-like
spherical
shape,
Mg
O
present.
Treatment
with
(10
mg/kg)
significant
improvement
spatial
non-spatial
memory
functions.
This
further
supported
biochemical
showing
improved
antioxidant
enzyme
(GSH,
SOD,
CAT,
GPx
activity)
activities
significantly
attenuated
activity
stress.
CH/PLA/MgONCs-treated
group,
observed
mitochondrial
complex
activity.
ICV-STZ-induced
as
indicated
increased
levels
TNF-α,
IL-6,
CRP,
reduced
treatment.
Additionally,
treated
histological
results
healthy
neuronal
cells
brain.
Furthermore,
silico
studies
confirm
these
molecules
have
good
binding
affinity
inhibit
Aβ
aggregation.
conclusion,
treatment
reversed
AD
pathology
improving
reducing
dysfunction.
These
findings
recommend
are
possible
therapeutic
agents
to
treat
AD.
Frontiers in Aging Neuroscience,
Journal Year:
2025,
Volume and Issue:
16
Published: Jan. 7, 2025
Alzheimer's
disease
(AD)
is
a
complex
neurodegenerative
disorder,
with
amyloid-beta
(Aβ)
aggregation
playing
key
role
in
its
pathogenesis.
Aβ-induced
oxidative
stress
leads
to
neuronal
damage,
mitochondrial
dysfunction,
and
apoptosis,
making
antioxidative
strategies
promising
for
AD
treatment.
This
study
investigates
the
effects
of
hydrogen-rich
water
(HRW)
zebrafish
model.
Zebrafish
were
exposed
aluminum
chloride
induce
AD-like
pathology
then
treated
HRW
using
nanobubble
device.
Behavioral
assays,
ELISA,
Hematoxylin-eosin
(H&E)
staining,
reactive
oxygen
species
(ROS)
neutrophil
fluorescence
labeling
employed
assess
HRW's
impact.
Additionally,
16S
rRNA
sequencing
analyzed
effect
on
gut
microbiota.
can
significantly
improve
cognitive
impairment
depression-like
behavior
model,
reduce
Aβ
deposition
(p
<
0.0001),
regulate
liver
Soluble
epoxide
hydrolase
(sEH)
levels
0.05),
neuroinflammation,
stress.
Furthermore,
reduced
number
harmful
bacteria
linked
by
restoring
balance
microbiota
gut.
These
findings
suggest
that
has
potential
as
therapeutic
strategy
targeting
stress,
inflammation,
gut-brain
axis
modulation.
Medicina,
Journal Year:
2023,
Volume and Issue:
59(3), P. 504 - 504
Published: March 4, 2023
Helicobacter
pylori
infection
consists
a
high
global
burden
affecting
more
than
50%
of
the
world's
population.
It
is
implicated,
beyond
substantiated
local
gastric
pathologies,
i.e.,
peptic
ulcers
and
cancer,
in
pathophysiology
several
neurodegenerative
disorders,
mainly
by
inducing
hyperhomocysteinemia-related
brain
cortical
thinning
(BCT).
BCT
has
been
advocated
as
possible
biomarker
associated
with
central
nervous
system
disorders
such
Alzheimer's
disease,
Parkinson's
multiple
sclerosis,
and/or
glaucoma,
termed
"ocular
disease".
According
to
hypothesis
relation
neurodegeneration,
non-commensal
gut
microbiome
trigger
mediator
diseases,
development
disease.
Among
others,
pylori-related
inflammatory
mediators,
defensins,
autophagy,
vitamin
D,
dietary
factors,
role
probiotics,
some
pathogenetic
considerations
including
relevant
involved
genes
are
discussed
within
this
opinion
article.
In
conclusion,
controlling
impact
hyperhomocysteinemia
on
might
offer
benefits,
additional
research
warranted
clarify
crucial
topic
currently
representing
major
worldwide
burden.
Antioxidants,
Journal Year:
2024,
Volume and Issue:
13(7), P. 862 - 862
Published: July 18, 2024
Alzheimer’s
disease
(AD)
is
a
progressive
neurodegenerative
disorder
that
comprises
amyloid-beta
protein
(Aβ)
as
main
component
of
neuritic
plaques.
Its
deposition
considered
trigger
for
AD
pathogenesis,
progression,
and
the
clinical
symptoms
cognitive
impairment.
Some
distinct
pathological
features
include
phosphorylation
tau
protein,
oxidative
stress,
mitochondrial
dysfunction.
These
consequences
tend
to
produce
reactive
oxygen
species
(ROS),
resulting
in
dysregulation
various
signaling
pathways
neuroinflammation
neurodegeneration.
The
relationship
between
Aβ
cascade
stress
pathogenesis
like
“chicken
egg”
story,
with
etiology
regarding
these
two
factors
remaining
question
“which
comes
first.”
However,
this
review,
we
have
tried
our
best
clarify
interconnection
mechanisms
show
precise
cause-and-effect
relationship.
Based
on
above
hallmarks
AD,
several
therapeutic
strategies
using
natural
antioxidants,
monoclonal
antibodies,
vaccines
are
employed
anti-Aβ
therapy
decrease
ROS,
burden,
chronic
neuroinflammation,
synaptic
failure.
antioxidants
immunotherapeutics
demonstrated
significant
neuroprotective
effects
symptomatic
relief
vitro
vivo
models,
well
trials
AD.
none
them
received
final
approval
enter
drug
market
mitigating
In
extensively
elaborate
pitfalls,
assurances,
important
crosstalk
concerning
current
therapy.
Additionally,
discuss
future
development
more
Aβ-targeted
approaches
optimization
treatment
mitigation.
Antioxidants,
Journal Year:
2023,
Volume and Issue:
12(8), P. 1536 - 1536
Published: July 31, 2023
Oxidative
stress
is
proven
to
be
a
leading
factor
in
multitude
of
adverse
conditions,
from
Alzheimer’s
disease
cancer.
Thus,
developing
effective
radical
scavenging
agents
eliminate
reactive
oxygen
species
(ROS)
driving
many
oxidative
processes
has
become
critical.
In
addition
conventional
antioxidants,
nanoscale
structures
and
metal–organic
complexes
have
recently
shown
promising
potential
for
scavenging.
To
design
an
optimal
ROS
agent,
we
synthesized
ten
types
biocompatible
graphene
quantum
dots
(GQDs)
augmented
with
various
metal
dopants.
The
abilities
these
novel
metal-doped
GQD
were,
the
first
time,
assessed
via
DPPH,
KMnO4,
RHB
(Rhodamine
B
protectant)
assays.
While
all
GQDs
consistently
demonstrate
antioxidant
properties
higher
than
undoped
cores,
aluminum-doped
exhibit
60–95%
ability
ascorbic
acid
positive
control.
Tm-doped
match
KMnO4
assay.
All
doped
possess
fluorescence
imaging
capabilities
that
enable
their
tracking
vitro,
ensuring
successful
cellular
internalization.
Given
such
multifunctionality,
antioxidants
can
prospective
candidates
multimodal
therapeutics,
including
reduction
concomitant
therapeutic
delivery
cancer
tumors.
ACS Chemical Neuroscience,
Journal Year:
2023,
Volume and Issue:
14(18), P. 3444 - 3459
Published: Sept. 5, 2023
Alzheimer's
disease
(AD)
is
one
of
the
most
prevalent
and
progressive
neurodegenerative
disorders,
hallmarked
by
increased
amyloid-β
deposition
enhanced
oxidative
load
in
brain,
ensuing
cognitive
decline.
The
present
study
aimed
at
elucidating
neuroprotective
effect
saroglitazar,
a
dual
peroxisome-proliferator-activated
receptor
(PPARα/γ)
agonist
used
treatment
diabetic
dyslipidemia,
against
memory
impairment
induced
intraperitoneal
scopolamine
injection.
30
male
Wistar
rats
were
randomly
divided
into
following
five
groups:
(A)
Veh
+
Veh,
(B)
SGZ
(C)
SCOP,
(D)
DPZ
(E)
SCOP.
Rats
respective
groups
pretreated
with
saroglitazar
(10
mg/kg,
p.o.)
donepezil
(3
once
daily
for
16
days.
During
final
9
days
study,
injection
i.p.)
was
administered
to
groups.
Adjacent
injection,
behavioral
tests
such
as
open
field,
Y
maze,
novel
object
recognition
test,
Morris
water
maze
conducted
assess
learning
memory.
Additionally,
biochemical
parameters
acetylcholinesterase
(AChE),
butyrylcholinesterase
(BuChE),
nitric
oxide
(NO),
malondialdehyde
(MDA),
reduced
glutathione
(GSH),
superoxide
dismutase
(SOD),
brain-derived
neurotrophic
factor
(BDNF),
β-amyloid
levels,
NF-κB
measured
hippocampus.
that
received
injections
showed
significantly
impaired
short-term
spatial
This
associated
an
increase
β-amyloid,
iNOS,
malondialdehyde,
NF-κB,
TNF-α
levels
hippocampus
AD
rats.
On
other
hand,
has
provided
promising
data
on
its
protective
role
cognition
protecting
BDNF,
SOD,
GSH
As
result,
found
be
therapy
upregulating
antioxidant
status
cholinergic
activity
preventing
loss.
Collectively,
findings
revealed
protected
suppressing
scopolamine-mediated
deficits,
stress,
damage.
Studying
these
mechanisms
may
conclude
AD.
However,
further
studies
transgenic
animals
will
provide
numerous
insights
contribute
developing
therapeutic
intervention
Journal of Alzheimer s Disease,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 26, 2025
Alzheimer's
disease
(AD)
is
a
progressive
neurodegenerative
disorder
that
primarily
affects
the
elderly,
leading
to
severe
cognitive
decline
and
loss
of
autonomy.
The
accumulation
amyloid-β
peptides
tau
proteins
in
brain
considered
central
pathogenic
mechanism,
which
results
neuronal
dysfunction
cell
death.
Various
metabolic
disruptions,
such
as
chronic
oxidative
stress
inflammatory
processes,
further
exacerbate
progression
AD.
This
review,
based
on
literature
from
PubMed,
SciELO,
MDPI,
ScienceDirect,
evaluates
role
bioactive
compounds
dietary
patterns,
specifically
Mediterranean
MIND
diets,
mitigating
These
rich
vitamins,
flavonoids,
carotenoids,
omega-3
fatty
acids,
have
shown
potential
reducing
damage
inflammation
brain,
offering
neuroprotective
benefits.
findings
suggest
vitamin
E
isomers
polyphenols
may
delay
decline,
presenting
promising
avenue
for
future
interventions
aimed
at
optimizing
consumption
these
prevent
or
slow
onset
Further
research
needed
determine
optimal
doses
combinations
maximize
their
protective
effects.